Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer [Response to Letter]

Thuraya S AlSumai¹, Amal Alhefdhi^{1

2}

Affiliations

¹ Department of Surgery, Section of Breast & Endocrine Surgery, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
² Faculty of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

Comment

Thuraya S AlSumai et al. Breast Cancer (Dove Med Press). 2023.

. 2023 Feb 6:15:133-134.

doi: 10.2147/BCTT.S404114. eCollection 2023.

Thuraya S AlSumai¹, Amal Alhefdhi^{1

2}

¹ Department of Surgery, Section of Breast & Endocrine Surgery, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
² Faculty of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

No abstract available

Conflict of interest statement

The authors report no conflicts of interest in this communication.

Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer [Letter].
Zhang JY, Xu BH. Zhang JY, et al. Breast Cancer (Dove Med Press). 2022 Dec 21;14:489-490. doi: 10.2147/BCTT.S400958. eCollection 2022. Breast Cancer (Dove Med Press). 2022. PMID: 36575688 Free PMC article. No abstract available.

1. Viale G, Zurrida S, Maiorano E, et al. Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer. 2005;103(3):492–500. doi:10.1002/cncr.20809 - DOI - PubMed
1. Minami S, Sakimura C, Irie J, Tokai Y, Okubo H, Ohno T. Predictive factors among clinicopathological characteristics for sentinel lymph node metastasis in T1-T2 breast cancer. Cancer Manag Res. 2021;13:215–223. doi:10.2147/CMAR.S284922 - DOI - PMC - PubMed
1. Olivotto IA, Jackson JS, Mates D, et al. Prediction of axillary lymph node involvement of women with invasive breast carcinoma: a multivariate analysis. Cancer. 1998;83(5):948–955. doi:10.1002/(SICI)1097-0142(19980901)83:5<948::AID-CNCR21>3.0.CO;2-U - DOI - PubMed
1. Galimberti V, Cole BF, Viale G, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled Phase 3 trial. Lancet Oncol. 2018;19(10):1385–1393. doi:10.1016/S1470-2045(18)30380-2 - DOI - PubMed
1. Brackstone M, Baldassarre FG, Perera FE, et al. Management of the axilla in early-stage breast cancer: Ontario health (cancer care Ontario) and ASCO guideline. J Clin Oncol. 2021;39(27):3056–3082. doi:10.1200/JCO.21.00934 - DOI - PubMed